首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Immunostimulatory Cationic Liposomes as Adjuvants in a Novel TB Vaccine
【24h】

Immunostimulatory Cationic Liposomes as Adjuvants in a Novel TB Vaccine

机译:免疫刺激性阳离子脂质体作为新型结核病疫苗的佐剂

获取原文

摘要

Immunostimulatory liposomes composed of dimethyldiotadecylammonium bromide (DDA), N-[l-(2,3-dioleoyloxy)propyl]-N,N,N-trimethyl ammonium chloride (DOTAP), [N-(N',N'-dimethylaminoethane)-carbonyl] cholesterol (DC-Choi) or N,N-dioleyl-N,N-dimethylammonium chloride (DODA), in combination with trehalose 6,6'-dibehenate (TDB) were characterized both with and without the candidate tuberculosis (TB) vaccine antigen Ag85B-ESAT-6 (HI). The biodistribution in mice of the vaccines was studied over a 14 day period using a duel-radiolabeling method.
机译:由二甲基二十二烷基溴化铵(DDA),N- [1-(2,3-二油酰氧基)丙基] -N,N,N-三甲基氯化铵(DOTAP),[N-(N',N'-二甲基氨基乙烷)组成的免疫刺激脂质体-羰基]胆固醇(DC-Choi)或N,N-二醇基-N,N-二甲基氯化铵(DODA)结合海藻糖6,6'-二山ate酸酯(TDB)的特征在于是否存在候选结核病(TB疫苗抗原Ag85B-ESAT-6(HI)。使用双放射性标记法研究了疫苗在小鼠中的生物分布,历时14天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号